TORONTO, April 27 /CNW/ - Patheon Inc. announced today that three
representatives from JLL Partners, Paul S. Levy, Ramsey A. Frank, and Thomas
S. Taylor, have joined Patheon's Board of Directors, effective immediately.
These appointments to the Board follow the approval by Patheon's shareholders
on April 19, 2007 of a US$150 million convertible preferred share investment
in Patheon by JLL Partners.
"We are pleased to welcome Messrs Levy, Frank and Taylor to our Board of
Directors," said Mr. Peter Green, Chairman of Patheon. "They are highly
experienced investors who have significant knowledge of the healthcare sector,
having made a number of successful investments in this space. We look forward
to working with them to drive strong growth in Patheon's revenues and
Paul Levy is a Managing Director of JLL Partners, which he founded in
1988. Prior to that, he served as a Managing Director of Drexel Burnham
Lambert and as a Chief Executive Officer of Yves Saint Laurent, Inc. He has
also worked as Vice President of Administration & General Counsel of Quality
Care, Inc. and as an attorney at Stroock & Stroock & Lavan LLP.
Ramsey Frank is a Managing Director of JLL Partners, which he joined in
1999. Prior to joining JLL, Mr. Frank served as a Managing Director of
Donaldson, Lufkin & Jenrette Securities Corporation and as a Managing Director
of Smith Barney & Co.
Thomas Taylor joined JLL in 2005 after serving as President and CEO of
EPIX Holdings, a human resource outsourcer. Prior to that, he served as Vice
President and Chief Financial Officer of Colorado Prime Corporation. He has
also worked at Kraft Foods as Vice President of Finance and Strategy and at
Central Soya as Vice President and Controller.
Patheon (TSX:PTI; www.patheon.com) is a leading global provider of drug
development and manufacturing services to the international pharmaceutical
industry. Patheon operates a network of 14 facilities in the United States,
Canada and Europe, employing more than 5,300 people and serving a client base
of 250 pharmaceutical and biotechnology companies.
ABOUT JLL PARTNERS
Founded in 1988, JLL Partners is a leading New York-based private equity
investment firm with $3.2 billion of capital under management. JLL's
investment philosophy is to partner with outstanding management teams and
invest with them in companies that they can continue to grow into market
leaders. JLL has invested in a variety of industries, with a specific focus on
healthcare services, financial services, business services and building
products. More information regarding JLL can be found on its website,
For further information:
For further information: Mr. Riccardo Trecroce, Chief Executive Officer,
Tel: (905) 812-6877, Fax: (905) 812-6613, Email: firstname.lastname@example.org